Lenire Tinnitus Treatment Cost: Clinic Prices, Insurance and the VA Route

Clinic package citations and separately required fees

The manufacturer posts no retail price. Its FAQ page, read on November 2, 2026, answers the cost question with one line: "The price range of Lenire depends on your prescribing healthcare professional." The only figures a buyer can check are the ones clinics publish for their own Lenire packages. We read three such pages on November 2, 2026 and quote one figure from each, in the clinic's own terms. They are observations from three providers, not a sample and not a national rate.

Sounds of Life Hearing Center, on a page read in November 2026 that says its prices were current in October 2026, separates a required $500 consultation from the $4,715 program and shows the combined $5,215, before any cost-sharing for diagnostic testing.

Timpanogos Hearing & Tinnitus, read on November 2, 2026, gives $4,000 to $5,000 for a Lenire treatment plan paid in full, without hearing aids; the same page also describes a financed plan that bundles other items, which we do not turn into a Lenire-only figure.

Elevate Audiology states on its FAQ page, read on November 2, 2026, that treatment with Lenire, including the consultation, the custom-programmed device and follow-up care, is $4,600; the page shows no date from which that price applies.

The three fees do not cover the same things. One clinic bills the consultation on its own line, one prices Lenire apart from hearing aids, and one folds the consultation and follow-up visits into a single amount. Before paying a deposit, ask the clinic for a written list of what its fee includes, which visits or hearing tests it bills separately, and whether any part can be sent to your plan. For what hearing aids sold with tinnitus features cost and who pays for them, see hearing aids for tinnitus.

HCPCS named-code search limits

Claims for devices and supplies sent to Medicare and many other payers use HCPCS Level II codes, a national code set maintained by CMS. We searched every descriptor in the October 2026 alpha-numeric HCPCS file for Lenire, for its model number CR-201 and for the word translingual. None of the three terms matched a descriptor. The string "neuromod" does appear, but only in descriptors for neuromodulation stimulator systems used alongside rehabilitation therapy, which name neither Lenire nor its maker.

That result is narrow on purpose. It shows that the October 2026 file has no code written for Lenire by name. It does not show that a clinic cannot put a generic code on a claim, and it does not predict how a plan treats a claim it receives. The clinic that bills chooses the codes, so the question to ask before treatment is which codes, if any, it intends to submit.

Medicare and commercial-plan wording

Neuromod's US coverage page, read on November 2, 2026, says: "At this time, Lenire is not broadly covered by major commercial insurance plans or Medicare in the United States."

That sentence is the manufacturer's statement. It is not a CMS national coverage determination, it is not a decision on anyone's claim, and it says nothing about appointments a clinic bills on their own, such as a hearing test. "Not broadly" also leaves room for a plan that decides differently. Original Medicare's rule on hearing aids, covered on our Medicare and hearing aids page, is a separate exclusion about hearing aids; we do not apply it to Lenire.

For Medicare Advantage, employer or marketplace coverage, the document that answers for you is your own plan's coverage text, or a written answer from the plan given before you pay. Ask the clinic for the codes first, since a plan can only answer about a claim it can identify.

VA procurement route

The Department of Veterans Affairs buys many medical products through Federal Supply Schedule contracts managed by its National Acquisition Center. The center's public catalogue, read on November 2, 2026, lists contract 36F79724D0114 held by Neuromod USA Inc.

A catalogue entry shows that a purchasing route exists for VA facilities. It does not say that a given veteran will be supplied the device, which clinics prescribe it, or what the VA pays, and we report no contract price. A veteran who receives care through the VA can ask the VA audiology clinic whether the device is available through it; the VA hearing aids page covers how VA hearing care is organized.

FDA administrative identity only

The FDA's Global Unique Device Identification Database (GUDID), read through openFDA on November 2, 2026, lists the brand Lenire, model CR-201, with NEUROMOD DEVICES LIMITED as the company. The record carries premarket submission number DEN210033; the DEN prefix marks a De Novo request.

We give these identifiers so that an invoice, a quote or a claim can be matched to the device record. They are administrative data only: the record states no price, no coverage decision and no clinical result, and nothing on this page draws one from it.